Command Palette

Search for a command to run...

Clinical Trials · NCT02664441

Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity

CompletedPhase 3Exenatide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Seattle Children's Hospital
Enrollment
42
Start date
Mar 2016
Locations
3 sites, United States
Primary endpoint
Percent Change of Body Mass Index (BMI) as Calculated by the Formula: Body Weight in kg Divided by Height in Meters².
View Exenatide compound reference